Clinical Trials on Hormone-sensitive Metastatic Breast Cancer in Switzerland
Total 353 results
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Matthias GuckenbergerRecruitingMetastatic CancerSwitzerland
-
University of Lausanne HospitalsUniversity Hospital, Zürich; Cantonal Hospital of St. GallenCompletedMetastatic Ovarian Cancer | Metastatic Cancer LungSwitzerland
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Swiss Group for Clinical Cancer ResearchTerminatedBreast Cancer | Metastatic Breast AdenocarcinomaSwitzerland
-
University Hospital, Basel, SwitzerlandNot yet recruiting
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
Vincent Vinh-HungVarian Medical SystemsActive, not recruitingBreast Cancer FemaleSwitzerland
-
Lindenhofgruppe AGUniversity of Bern; StiftungLindenhofTerminatedBreast Cancer FemaleSwitzerland
-
Manuela EicherSwiss Cancer League; Lindenhofgruppe AGCompletedBreast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast CancerSwitzerland
-
University Hospital, Basel, SwitzerlandETH Zurich - The Aceto LabCompletedBreast Cancer | Circulating Tumor Cells (CTCs)Switzerland
-
Centre Hospitalier Universitaire VaudoisRecruitingTriple Negative Breast CancerSwitzerland
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Brust-Zentrum AGCompleted
-
Centre Hospitalier Universitaire VaudoisTerminatedBreast Cancer | Lung CancerSwitzerland
-
Aline ReinmannCompletedCancer, Breast | Cancer, GynecologicSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Swiss Federal Institute of TechnologyKantonsspital BadenCompletedBreast CancerSwitzerland
-
University of ZurichTerminated
-
Kantonsspital Winterthur KSWTerminatedBreast Cancer, Invasive DuctalSwitzerland
-
University Hospital, Basel, SwitzerlandSt. Clara Research Ltd.TerminatedMetastatic Pancreatic CancerSwitzerland
-
Ente Ospedaliero Cantonale, BellinzonaPolitecnico di Milano; Clinical Trial Unit Ente Ospedaliero CantonaleCompleted
-
Palleos Healthcare GmbHmobile Health AGRecruiting
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Centre Hospitalier Universitaire VaudoisUnknownColorectal Cancer | Metastatic CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Breast Cancer | Bone Metastases | Metastatic Prostate CancerSwitzerland, Germany, Austria
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, United Kingdom, Spain, Switzerland
-
Christian SchweglerRecruitingChemotherapy Effect | Breast Cancer FemaleSwitzerland
-
European Organisation for Research and Treatment...CompletedBreast CancerSwitzerland
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Clinica Luganese MoncuccoSwiss National Science Foundation; Curzio Rüegg, MD, Head of Department, University... and other collaboratorsCompletedBreast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital, Basel, SwitzerlandSanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer LeagueCompletedMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerSwitzerland
-
European Organisation for Research and Treatment...TerminatedMetastatic CancerFrance, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
-
University Hospital, Basel, SwitzerlandCompletedBreast CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandRecruiting
-
OnkoZentrum Zürich AGUniversity of Zurich; Palleos Healthcare GmbHCompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported OutcomeSwitzerland
-
Centre Hospitalier Universitaire VaudoisUnknown